RRM1 is mediated by histone acetylation through gemcitabine resistance and contributes to invasiveness and ECM remodeling in pancreatic cancer

Hiroaki Ono(Kyushu University), Minoru Tanabe(Tokyo Medical and Dental University)
International Journal of Oncology
March 2, 2023
Cited by 33


Related Papers